IVY RX Weight Loss Review 2026: Injectable GLP-1 Program Details + How Tablet and "Sublingual" Options Compare
New Consumer Guide Compares Injectable, Tablet, and Sublingual GLP-1 Formats While Outlining FDA Guidance on Compounded Semaglutide Products
MIAMI, January 16, 2026 (Newswire.com) - Disclaimer: This article is for informational purposes only and does not constitute medical advice. Weight management concerns should be evaluated by qualified healthcare professionals. Always consult a qualified healthcare professional before starting any prescription treatment. This article contains affiliate links-if you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented.
If you have been researching telehealth options for GLP-1 weight loss medications, you have likely encountered IVY RX among the growing number of platforms connecting patients with licensed providers who may prescribe compounded GLP-1 injections. The promise of accessible, affordable weight management medication delivered directly to your door sounds appealing. However, understanding exactly what compounded medications are, how they differ from FDA-approved products, and what questions to ask before starting is essential for making an informed decision about your health.
The Most Important Thing to Understand First
IVY RX's program may provide access to a compounded injectable GLP-1 medication if a licensed clinician determines it is appropriate for you. This is not Ozempic, Wegovy, or any other brand-name product. According to the company's published disclosures, compounded medications are prepared by licensed pharmacies based on individual prescriptions and are not reviewed or approved by the FDA as finished products.
The FDA does not verify the safety, effectiveness, or quality of compounded medications before they reach patients. This distinction matters because the finished compounded product has not undergone FDA premarket review, so patients should verify the source of the medication and ask the prescriber or pharmacy about compounding standards and quality safeguards. IVY RX states that their partner pharmacy operates in FDA-registered facilities compliant with 503B and USP 797 standards. Note: FDA registration is not the same as FDA approval of a compounded medication.
How We Evaluated
This review was conducted using publicly available information and does not represent a clinical evaluation, endorsement, or recommendation.
Our methodology included:
Reviewed IVY RX public website disclosures and published program information
Reviewed FDA guidance on compounded GLP-1 medications, including enforcement discretion policies and safety communications
Evaluated program structure, pricing transparency, and safety disclosures as presented on the company's website
Did not evaluate effectiveness, outcomes, or patient results
Did not perform medical testing or make clinical recommendations
This article is educational and presents information for readers to consider when making their own healthcare decisions in consultation with licensed providers.
Who Is IVY RX?
IVY RX (IVY RX PLLC) is a telehealth platform headquartered in Miami, Florida. According to their published materials, the company connects patients with licensed medical providers who evaluate whether prescription medications-including compounded GLP-1 injections-are appropriate based on submitted health information.
The company states they have served over 200,000 members and maintain a 4.5-star rating from 3,000+ reviews according to their website. Their medical advisory board includes board-certified physicians in hematology, oncology, and related specialties.
It is important to understand the three-entity structure at play here:
IVY RX (the platform) facilitates connections between patients and providers, operates the technology, and handles billing and customer service.
Licensed providers (the clinicians) independently evaluate your health information and make prescribing decisions. IVY RX states that all affiliated providers are board-certified, US-licensed healthcare professionals. The platform cannot guarantee any individual will receive a prescription-that clinical determination rests entirely with the evaluating provider.
Partner pharmacies (the compounders) prepare and ship medications based on valid prescriptions. IVY RX states their pharmacy partners operate in FDA-registered facilities compliant with 503B and USP 797 standards, which are industry benchmarks for sterile compounding. Note: FDA registration is not the same as FDA approval of a compounded medication.
What IVY RX Is NOT
Before exploring whether this platform might be appropriate for you, it helps to understand what IVY RX does not offer:
IVY RX is not an emergency medical service. For urgent symptoms, contact emergency services or visit an emergency room.
IVY RX is not a substitute for in-person care when complex medical conditions require hands-on evaluation.
IVY RX does not guarantee a prescription. A licensed clinician makes that determination based on your health information.
IVY RX does not provide FDA-approved finished products. Their GLP-1 medication is compounded, which is a different regulatory category.
IVY RX does not guarantee specific results. Weight loss outcomes depend on many individual factors beyond medication alone.
Is IVY RX Right for You? A Self-Assessment Framework
These are common clinical criteria used for FDA-approved chronic weight management medications; only a licensed clinician can determine whether any treatment is appropriate for you.
You may be a good candidate if:
Many FDA-approved chronic weight management medications use criteria such as BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related condition. A licensed clinician will determine whether any medication is appropriate for you.
You have tried lifestyle modifications-diet and exercise-without achieving your weight management goals.
You understand that GLP-1 medication is not a standalone solution and requires ongoing commitment to healthier eating and physical activity.
You are comfortable with self-administered weekly injections.
You have no contraindications to GLP-1 medications, including personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
You are not currently pregnant, planning to become pregnant within 2 months, or breastfeeding.
You may want to reconsider if:
You are seeking Ozempic, Wegovy, or other FDA-approved brand-name products-IVY RX provides compounded semaglutide, which is not the same product.
You have a history of severe gastrointestinal disease, pancreatitis, or gallbladder problems.
You are looking for a "quick fix" without commitment to lifestyle changes.
You are uncomfortable with the distinction between compounded and FDA-approved medications.
You have complex medical conditions that require in-person evaluation and monitoring.
What IVY RX Actually Offers
According to the company's website, the IVY RX GLP-1 program includes:
Medication: Compounded injectable semaglutide (one vial per month with four doses, as described on the IVY RX website) prepared by a partner pharmacy operating in compliance with 503B and USP 797 standards.
Provider access: 24/7 messaging access to licensed providers through a secure patient portal for questions, dosage adjustments, and ongoing support.
Supplies: Injection supplies and home kit included with medication shipment.
Shipping: Free temperature-controlled shipping. IVY RX states delivery typically occurs within approximately 2 days of prescription approval.
What Arrives When You Order
According to IVY RX's website, approved orders include the following:
Temperature-controlled packaging: Medication ships with cold packs to maintain proper storage temperature during transit.
One vial of compounded semaglutide: Contains your monthly supply as prescribed by your provider.
Injection supplies: Syringes and alcohol swabs included for self-administration.
Dosing instructions: Written guidance on how to measure and administer your prescribed dose.
Patient portal access: Secure messaging with your assigned provider for questions or concerns.
Refill timing: IVY RX states that refills are shipped automatically based on your subscription schedule, with messaging reminders before shipment.
IVY RX Pricing: January 2026
According to IVY RX's website, pricing is structured as follows:
12-Month Plan: $1,980 total ($165 per month when paid upfront)
6-Month Plan: $1,350 total ($225 per month when paid upfront)
3-Month Plan: $780 total ($260 per month when paid upfront)
1-Month Plan: $295 total
IVY RX states they do not require insurance and offer transparent pricing. The company indicates that GLP-1 therapy may be HSA/FSA-eligible, but you should verify eligibility with your specific plan administrator.
Current Promotion: According to their website, new monthly subscribers can use code NY30 for $30 off their first month. This promotion expires January 31, 2026.
View the current IVY RX GLP-1 Weight Loss offer (official IVY RX site, affiliate link)
The IVY RX Process: What to Expect
According to the company's website, the process involves three main steps:
Step 1: Health Assessment
You complete an online questionnaire about your health history, current medications, lifestyle factors, and weight management goals. The company states this takes approximately 5 minutes.
Step 2: Provider Evaluation
A licensed medical provider reviews your submitted information and determines whether GLP-1 medication is appropriate for you. The platform cannot guarantee that any individual will receive a prescription-that clinical determination rests with the evaluating provider.
Step 3: Medication Delivery
If a provider writes a prescription, IVY RX states that medication is shipped from an FDA-registered pharmacy. Note: FDA registration is not the same as FDA approval of a compounded medication. According to the company, delivery typically occurs within approximately 2 days, with free temperature-controlled shipping included.
Injectable vs Tablet vs "Sublingual" GLP-1 Options: What to Know
This comparison is provided for educational context only and does not imply availability, equivalence, or endorsement of non-injectable GLP-1 formats by IVY RX.
IVY RX's weight loss program reviewed here focuses on injectable compounded GLP-1 medication when prescribed. The formats discussed below reflect other GLP-1 options consumers may see marketed elsewhere and are included for general educational comparison only.
Injectable GLP-1 Medications
Injectable GLP-1 receptor agonists are the most established format for this medication class. FDA-approved injectable brands include Ozempic (semaglutide, approved for type 2 diabetes), Wegovy (semaglutide, approved for chronic weight management), and Zepbound (tirzepatide, approved for chronic weight management).
Compounded injectable semaglutide, such as what may be prescribed through IVY RX's program, is prepared by compounding pharmacies and is not an FDA-approved finished product. Injectable formats require clinical oversight for proper dosing and administration.
Oral and Tablet GLP-1 Medications
There is one FDA-approved oral semaglutide product: Rybelsus, which is approved for type 2 diabetes management (not weight loss). Oral semaglutide requires specific administration instructions, including taking on an empty stomach with limited water.
Consumers may encounter marketing online for "oral compounded Ozempic" or similar products. These are not the same as FDA-approved oral semaglutide. If considering any oral GLP-1 product, verify the source, confirm pharmacy licensure, and understand whether you are receiving an FDA-approved product or a compounded preparation.
"Sublingual" Drops, Lozenges, and Similar Formats
Some online platforms market GLP-1 medications as sublingual drops, lozenges, or similar non-injectable formats. These formats are often promoted as needle-free alternatives.
Consumers should be aware that published clinical evidence for sublingual GLP-1 delivery is limited compared to injectable formats. FDA has encouraged consumers to verify sources, confirm pharmacy licensure, and ask questions about how medications are compounded before purchasing any GLP-1 product online.
If you encounter any GLP-1 product marketed in an unfamiliar format, ask the prescriber and pharmacy directly about sourcing, compounding standards, and what clinical evidence supports that delivery method.
Safety Considerations
GLP-1 medications are associated with both common side effects and serious potential risks. The following information is drawn from the company's published safety disclosures and general prescribing information. This is not a complete list of risks or precautions-always review the full safety information provided with your prescription and discuss concerns with your healthcare provider.
Common Side Effects
According to IVY RX's published safety information, commonly reported side effects include nausea, vomiting, stomach upset, abdominal pain, constipation, diarrhea, heartburn, excessive belching and gas, dizziness, headaches, and fatigue.
The company notes that most side effects are temporary and may resolve as the body adjusts. IVY RX states that dosage adjustments can be made through the platform's messaging system.
Serious Warnings
Some GLP-1 receptor agonist medications (including semaglutide and tirzepatide products) carry a boxed warning-the FDA's most serious warning-regarding thyroid C-cell tumors. In rodent studies, these medications caused thyroid tumors including thyroid cancer. It is not known whether they cause thyroid tumors or medullary thyroid carcinoma (MTC) in humans.
Do not use GLP-1 medications if you or any family member has a history of:
Medullary thyroid carcinoma (MTC)
Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Seek immediate medical attention if you experience:
A lump or swelling in your neck, trouble swallowing, hoarseness, or shortness of breath
Severe abdominal pain that does not go away (possible pancreatitis)
Signs of allergic reaction including swelling of face, lips, tongue, or throat
Symptoms of low blood sugar (dizziness, confusion, rapid heartbeat, sweating)
Changes in vision (particularly if you have diabetic retinopathy)
Pain in upper stomach, fever, or yellowing of skin or eyes (possible gallbladder issues)
Dosing Accuracy Matters With Compounded Vials
FDA has warned about dosing errors with compounded injectable semaglutide, including cases where patients or clinicians miscalculated dose conversions (for example, milligrams to units or milliliters). Ask your prescriber or pharmacist to confirm your exact dose and show you how to measure it using the syringe provided.
How to Avoid Dosing Mistakes
Ask your provider for your dose in both milligrams (mg) and the corresponding volume (mL or units)
Request that the pharmacy mark the correct syringe level for your dose
Ask for written instructions showing exactly how to draw up and administer medication
Do not estimate or "eyeball" doses-use the exact measurement every time
Contact your provider immediately if you are uncertain about any aspect of dosing
FDA Caution About Additional Ingredients
FDA has noted that some compounded semaglutide products include additional ingredients (such as vitamins like B12, B6, L-carnitine, or NAD). The safety and effectiveness of combining semaglutide with other ingredients has not been established. Ask your prescriber or pharmacy whether your medication contains any ingredients beyond semaglutide.
Additional Precautions
GLP-1 medications may cause kidney problems, particularly if dehydration occurs from nausea, vomiting, or diarrhea. The company advises staying well-hydrated while on medication.
These medications delay gastric emptying and may affect absorption of other oral medications. Discuss timing of all medications with your healthcare provider.
Do not use if pregnant, planning to become pregnant, or breastfeeding. If planning pregnancy, discontinue at least 2 months before trying to conceive.
Understanding Compounded Semaglutide
The GLP-1 telehealth industry is currently under significant regulatory scrutiny. FDA has stated that the shortage of semaglutide injection products is resolved (FDA update dated February 21, 2025). FDA has also published policy updates describing how it intends to apply enforcement discretion for certain compounded semaglutide injection products, depending on whether they are compounded under section 503A or 503B and other conditions. Because these policies have changed over time, patients should review the most current FDA guidance and ask their prescriber or pharmacy how their product is sourced and compounded.
503A vs 503B Compounding: What It Means
Section 503A refers to traditional compounding pharmacies that prepare medications based on individual patient prescriptions, typically in smaller quantities. Section 503B refers to outsourcing facilities that can compound larger batches without patient-specific prescriptions and are subject to additional FDA oversight, including current good manufacturing practice (CGMP) requirements.
IVY RX states their partner pharmacy operates under 503B standards. When evaluating any compounded medication, consider asking: Is this compounded under 503A or 503B? What quality standards does the facility follow? How is the active ingredient sourced? These questions can help you understand how your medication is produced.
Important note about salt forms: FDA has stated that some products marketed as "semaglutide" may be made using salt forms (including semaglutide sodium and semaglutide acetate), which are different active ingredients than those used in FDA-approved drugs. FDA notes these salt forms should not be used to compound semaglutide. Ask your prescriber or dispensing pharmacy what form is used and follow the prescribed dosing instructions exactly.
To report any suspected adverse reactions to compounded semaglutide, contact the FDA at 1-800-FDA-1088 or visit FDA MedWatch.
How to Verify the Pharmacy and Prescriber
Before starting any telehealth-prescribed medication, consider taking these verification steps:
Verify prescriber licensure: Check your state medical board's website to confirm the prescribing provider holds an active, valid license in your state.
Verify pharmacy licensure: Check your state board of pharmacy's website to confirm the dispensing pharmacy holds appropriate licensure.
Ask about compounding standards: Request information about whether the pharmacy operates under 503A or 503B, what quality standards they follow, and whether they have any recent inspection findings.
Confirm the active ingredient: Ask specifically whether the semaglutide used is the same form as FDA-approved products, or whether it uses a salt form.
Review the label: When medication arrives, verify the pharmacy name and address on the label matches what you were told, and that dosing instructions are clear.
Frequently Asked Questions
Is IVY RX legitimate?
IVY RX (IVY RX PLLC) is a registered telehealth company based in Miami, Florida. According to their published materials, they have served over 200,000 members. As with any healthcare decision, verify current licensing and regulatory standing before enrolling.
How much does IVY RX weight loss cost in 2026?
According to IVY RX's website, pricing ranges from $165 per month (12-month plan paid upfront at $1,980 total) to $295 per month (month-to-month plan). Current promotions may offer additional savings for new subscribers.
Is IVY RX compounded semaglutide FDA-approved?
No. Compounded medications are not reviewed or approved by the FDA as finished products. IVY RX's GLP-1 medication is prepared by a compounding pharmacy based on individual prescriptions. This is different from FDA-approved products like Ozempic or Wegovy, which have undergone clinical trials and regulatory review.
How do injectable and oral GLP-1s differ?
Injectable GLP-1 medications are administered via subcutaneous injection, typically weekly. FDA-approved injectable options include Ozempic, Wegovy, and Zepbound. There is one FDA-approved oral semaglutide (Rybelsus) for diabetes, which requires specific administration on an empty stomach. Compounded injectable semaglutide, like what may be prescribed through IVY RX, is not an FDA-approved finished product. Consumers should verify the source and regulatory status of any GLP-1 product before use.
How do I verify what form of semaglutide is used?
Ask your prescriber or the dispensing pharmacy directly. Specifically ask whether the semaglutide is the same form used in FDA-approved products, or whether it is a salt form (such as semaglutide sodium or semaglutide acetate). FDA has noted that salt forms are different active ingredients and should not be used to compound semaglutide.
Can anyone get GLP-1 medication through IVY RX?
No. A licensed medical provider must evaluate your health information and determine whether GLP-1 medication is appropriate for you. Individuals with contraindications-including personal or family history of medullary thyroid carcinoma or MEN 2-are not candidates for this medication. The platform cannot guarantee that any individual will receive a prescription.
What happens if I experience side effects?
According to IVY RX, customers have 24/7 access to licensed providers through secure messaging. Dosage adjustments can be made based on your response. For serious side effects, you should seek appropriate medical care, which may include emergency services depending on symptom severity.
Can I cancel my subscription?
You may cancel your subscription by contacting IVY RX support. Cancellation timing, billing cycles, and any refund eligibility vary by plan and are governed by IVY RX's published terms and refund policy.
Does IVY RX accept insurance?
According to IVY RX, they do not require insurance and offer transparent pricing. The company states GLP-1 therapy may be HSA/FSA-eligible, but you should verify eligibility with your specific plan administrator.
The Bottom Line
IVY RX offers a telehealth pathway to compounded injectable GLP-1 medications at price points that are materially lower than many branded alternatives, based on publicly listed pricing. Their published pricing starts at $165 per month for long-term commitments, with 24/7 provider access and temperature-controlled shipping included.
However, prospective patients should clearly understand that compounded semaglutide is not an FDA-approved finished product, and the regulatory environment for these medications is actively evolving. The decision to use a compounded medication involves accepting certain trade-offs that each individual must weigh based on their circumstances, preferences, and risk tolerance.
If you are considering IVY RX, the most important steps are to honestly complete the health assessment, ask questions about anything you do not understand, and maintain open communication with the assigned provider about your response to treatment.
View the current IVY RX GLP-1 Weight Loss offer (official IVY RX site, affiliate link)
Email: [email protected]
Disclaimers
Content and Medical Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. The descriptions of potential benefits are not guarantees and are not a substitute for an individualized medical evaluation. IVY RX's compounded GLP-1 medication is a prescription medication that requires evaluation by a licensed clinician. The information provided here does not replace the professional judgment of your healthcare provider.
Professional Medical Disclaimer: This article is educational and does not constitute medical advice. Prescription GLP-1 medication is not a substitute for prescribed medical treatment for diabetes or other health conditions. If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your physician before starting any new prescription treatment. Do not change, adjust, or discontinue any medications or prescribed treatments without your physician's guidance and approval.
Compounded Medication Notice: IVY RX's compounded GLP-1 injection is a prescription medication prepared by a licensed pharmacy based on an individual prescription. Compounded medications are not reviewed or approved by the FDA as finished products. The FDA does not verify the safety, effectiveness, or quality of compounded medications before marketing. They are prepared using active ingredients under the direction of a prescribing clinician.
Results May Vary: Individual results will vary based on factors including age, baseline health condition, starting weight, metabolic factors, consistency of use, adherence to lifestyle modifications, genetic factors, current medications, and other individual variables. Results are not guaranteed and depend on many factors beyond medication alone.
FTC Affiliate Disclosure: This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy, neutrality, or integrity of the information presented. All descriptions are based on publicly available information from IVY RX's official website.
Pricing Disclaimer: All prices, discounts, and promotional offers mentioned were accurate at the time of publication (January 2026) but are subject to change without notice. Always verify current pricing and terms on the official IVY RX website before making your purchase.
Publisher Responsibility: The publisher of this article has made every effort to ensure accuracy at the time of publication. We do not accept responsibility for errors, omissions, or outcomes resulting from the use of the information provided. Readers are encouraged to verify all details directly with IVY RX and their healthcare provider before making decisions.
Insurance Coverage Note: Many direct-to-consumer prescription products are not covered by traditional insurance plans, but coverage policies vary. Always confirm benefits directly with your insurer. Some HSA/FSA plans may reimburse qualifying expenses. Check your specific plan rules.
Last updated: January 2026
SOURCE: Ivy RX
Source: Ivy RX
Share:
Tags: Compounded Medications, Consumer Health Guide, GLP-1 Weight Loss, Telehealth Programs